Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Neurocritical Care
Published in: Neurocritical Care 2/2011

01-10-2011 | Review

Cardiovascular and Pulmonary Complications of Aneurysmal Subarachnoid Hemorrhage

Published in: Neurocritical Care | Issue 2/2011

Login to get access

Abstract

Cardiopulmonary complications after aneurysmal subarachnoid hemorrhage negatively affect overall morbidity and mortality. An electronic literature search was performed for English-language articles focused on cardiopulmonary complications with subarachnoid hemorrhage published through October 2010. A total of 278 citations were identified, including 72 clinical studies. In most cases, study quality was low or very low. Cardiac injury, evidenced by an elevation in troponin levels, is reported in about one-third of patients after aneurysmal subarachnoid hemorrhage. Arrhythmias also occur in about one-third of patients after subarachnoid hemorrhage. The incidence of pulmonary complications, especially neurogenic pulmonary edema, is more difficult to establish from available literature. Cardiopulmonary complications have been linked to worsened clinical outcome, suggesting a role for cardiac monitoring and interventions.
Literature
1.
Cropp GJ, Manning GW. Electrocardiographic changes simulating myocardial ischemia and infarction associated with spontaneous intracranial hemorrhage. Circulation. 1960;22:25–38.PubMed
2.
3.
Weinberg SJ, Fuster JM. Electrocardiographic changes produced by localized hypothalamic stimulations. Ann Intern Med. 1960;53:332–41.PubMed
4.
Doshi R, Neil-Dwyer G. Hypothalamic and myocardial lesions after subarachnoid haemorrhage. J Neurol Neurosurg Psychiatr. 1977;40:821–6.PubMedCrossRef
5.
Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. BMJ. 2004;328:1490.PubMedCrossRef
6.
Miketic JK, Hravnak M, Sereika SM, Crago EA. Elevated cardiac troponin I and functional recovery and disability in patients after aneurysmal subarachnoid hemorrhage. Am J Crit Care. 2010;19:522–8.PubMedCrossRef
7.
Jyotsna M, Prasad V, Indrani G, Trikamji BV. Importance of detection of segmental wall motion abnormalities of left ventricle in nontraumatic subarachnoid hemorrhage: a prospective study. Echocardiography. 2010;27:496–500.PubMedCrossRef
8.
Ichinomiya T, Terao Y, Miura K, et al. QTc interval and neurological outcomes in aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2010;13:347–54.PubMedCrossRef
9.
Vannemreddy P, Venkatesh P, Dinesh K, Reddy P, Nanda A. Myocardial dysfunction in subarachnoid hemorrhage: prognostication by echo cardiography and cardiac enzymes. A prospective study. Acta Neurochir Suppl. 2009;106:151–4.CrossRef
10.
Sandvei MS, Amundsen BH, Haugen BO, Stoylen A, Slordahl SA, Vik A. Left ventricular myocardial function during the acute phase of a subarachnoid haemorrhage. Scand Cardiovasc J. 2009;43:110–6.PubMedCrossRef
11.
Meaudre E, Jego C, Kenane N, et al. B-type natriuretic peptide release and left ventricular filling pressure assessed by echocardiographic study after subarachnoid hemorrhage: a prospective study in non-cardiac patients. Crit Care. 2009;13:R76.PubMedCrossRef
12.
Jung JH, Min PK, Rim SJ, Ha JW, Chung N, Lee KC. Are electrocardiographic changes in patients with acute subarachnoid hemorrhage associated with Takotsubo cardiomyopathy? Cardiology. 2009;115:98–106.PubMedCrossRef
13.
Hravnak M, Frangiskakis JM, Crago EA, et al. Elevated cardiac troponin I and relationship to persistence of electrocardiographic and echocardiographic abnormalities after aneurysmal subarachnoid hemorrhage. Stroke. 2009;40:3478–84.PubMedCrossRef
14.
Frangiskakis JM, Hravnak M, Crago EA, et al. Ventricular arrhythmia risk after subarachnoid hemorrhage. Neurocrit Care. 2009;10:287–94.PubMedCrossRef
15.
Abdelmoneim SS, Wijdicks EF, Lee VH, et al. Real-time myocardial perfusion contrast echocardiography and regional wall motion abnormalities after aneurysmal subarachnoid hemorrhage. J Neurosurg. 2009;111:1023–8.PubMedCrossRef
16.
Tanabe M, Crago EA, Suffoletto MS, et al. Relation of elevation in cardiac troponin I to clinical severity, cardiac dysfunction, and pulmonary congestion in patients with subarachnoid hemorrhage. Am J Cardiol. 2008;102:1545–50.PubMedCrossRef
17.
Sugimoto K, Watanabe E, Yamada A, et al. Prognostic implications of left ventricular wall motion abnormalities associated with subarachnoid hemorrhage. Int Heart J. 2008;49:75–85.PubMedCrossRef
18.
Softeland Sandvei M, Amundsen BH, Olav Haugen B, Stoylen A, Slordahl SA, Vik A. Left ventricular function during the acute phase of a subarachnoid haemorrhage. Scand Cardiovasc J. 2008:1–7.
19.
Sandhu R, Aronow WS, Rajdev A, et al. Relation of cardiac troponin I levels with in-hospital mortality in patients with ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage. Am J Cardiol. 2008;102:632–4.PubMedCrossRef
20.
Ramappa P, Thatai D, Coplin W, et al. Cardiac troponin-I: a predictor of prognosis in subarachnoid hemorrhage. Neurocrit Care. 2008;8:398–403.PubMedCrossRef
21.
Frontera JA, Parra A, Shimbo D, et al. Cardiac arrhythmias after subarachnoid hemorrhage: risk factors and impact on outcome. Cerebrovasc Dis. 2008;26:71–8.PubMedCrossRef
22.
Urbaniak K, Merchant AI, Amin-Hanjani S, Roitberg B. Cardiac complications after aneurysmal subarachnoid hemorrhage. Surg Neurol. 2007;67:21–8.PubMedCrossRef
23.
Mutoh T, Kazumata K, Ajiki M, Ushikoshi S, Terasaka S. Goal-directed fluid management by bedside transpulmonary hemodynamic monitoring after subarachnoid hemorrhage. Stroke. 2007;38:3218–324.PubMedCrossRef
24.
Koenig MA, Puttgen HA, Prabhakaran V, Reich D, Stevens RD. B-type natriuretic peptide as a marker for heart failure in patients with acute stroke. Intensive Care Med. 2007;33:1587–93.PubMedCrossRef
25.
Yarlagadda S, Rajendran P, Miss JC, et al. Cardiovascular predictors of in-patient mortality after subarachnoid hemorrhage. Neurocrit Care. 2006;5:102–7.PubMedCrossRef
26.
Lee VH, Connolly HM, Fulgham JR, Manno EM, Brown RD Jr, Wijdicks EF. Tako-tsubo cardiomyopathy in aneurysmal subarachnoid hemorrhage: an underappreciated ventricular dysfunction. J Neurosurg. 2006;105:264–70.PubMedCrossRef
27.
Kothavale A, Banki NM, Kopelnik A, et al. Predictors of left ventricular regional wall motion abnormalities after subarachnoid hemorrhage. Neurocrit Care. 2006;4:199–205.PubMedCrossRef
28.
Banki N, Kopelnik A, Tung P, et al. Prospective analysis of prevalence, distribution, and rate of recovery of left ventricular systolic dysfunction in patients with subarachnoid hemorrhage. J Neurosurg. 2006;105:15–20.PubMedCrossRef
29.
Tung PP, Olmsted E, Kopelnik A, et al. Plasma B-type natriuretic peptide levels are associated with early cardiac dysfunction after subarachnoid hemorrhage. Stroke. 2005;36:1567–9.PubMedCrossRef
30.
Schuiling WJ, Dennesen PJ, Tans JT, Kingma LM, Algra A, Rinkel GJ. Troponin I in predicting cardiac or pulmonary complications and outcome in subarachnoid haemorrhage. J Neurol Neurosurg Psychiatr. 2005;76:1565–9.PubMedCrossRef
31.
Naidech AM, Kreiter KT, Janjua N, et al. Cardiac troponin elevation, cardiovascular morbidity, and outcome after subarachnoid hemorrhage. Circulation. 2005;112:2851–6.PubMedCrossRef
32.
Naidech A, Du Y, Kreiter KT, et al. Dobutamine versus milrinone after subarachnoid hemorrhage. Neurosurgery. 2005;56:21–61.PubMed
33.
Kopelnik A, Fisher L, Miss JC, et al. Prevalence and implications of diastolic dysfunction after subarachnoid hemorrhage. Neurocrit Care. 2005;3:132–8.PubMedCrossRef
34.
Khush K, Kopelnik A, Tung P, et al. Age and aneurysm position predict patterns of left ventricular dysfunction after subarachnoid hemorrhage. J Am Soc Echocardiogr. 2005;18:168–74.PubMedCrossRef
35.
Banki NM, Kopelnik A, Dae MW, et al. Acute neurocardiogenic injury after subarachnoid hemorrhage. Circulation. 2005;112:3314–9.PubMedCrossRef
36.
Tung P, Kopelnik A, Banki N, et al. Predictors of neurocardiogenic injury after subarachnoid hemorrhage. Stroke. 2004;35:548–51.PubMedCrossRef
37.
Reinprecht A, Greher M, Wolfsberger S, Dietrich W, Illievich UM, Gruber A. Prone position in subarachnoid hemorrhage patients with acute respiratory distress syndrome: effects on cerebral tissue oxygenation and intracranial pressure. Crit Care Med. 2003;31:1831–8.PubMedCrossRef
38.
Deibert E, Barzilai B, Braverman AC, et al. Clinical significance of elevated troponin I levels in patients with nontraumatic subarachnoid hemorrhage. J Neurosurg. 2003;98:741–6.PubMedCrossRef
39.
Zaroff JG, Rordorf GA, Ogilvy CS, Picard MH. Regional patterns of left ventricular systolic dysfunction after subarachnoid hemorrhage: evidence for neurally mediated cardiac injury. J Am Soc Echocardiogr. 2000;13:774–9.PubMedCrossRef
40.
Parekh N, Venkatesh B, Cross D, et al. Cardiac troponin I predicts myocardial dysfunction in aneurysmal subarachnoid hemorrhage. J Am Coll Cardiol. 2000;36:1328–35.PubMedCrossRef
41.
Zaroff JG, Rordorf GA, Newell JB, Ogilvy CS, Levinson JR. Cardiac outcome in patients with subarachnoid hemorrhage and electrocardiographic abnormalities. Neurosurgery. 1999;44:34–9.PubMedCrossRef
42.
Mayer SA, Lin J, Homma S, et al. Myocardial injury and left ventricular performance after subarachnoid hemorrhage. Stroke. 1999;30:780–6.PubMedCrossRef
43.
Neil-Dwyer G, Walter P, Cruickshank JM. Beta-blockade benefits patients following a subarachnoid haemorrhage. Eur J Clin Pharmacol. 1985;28(Suppl):25–9.PubMedCrossRef
44.
Walter P, Neil-Dwyer G, Cruickshank JM. Beneficial effects of adrenergic blockade in patients with subarachnoid haemorrhage. Br Med J (Clin Res Ed). 1982;284:1661–4.CrossRef
45.
Neil-Dwyer G, Walter P, Cruickshank JM, Doshi B, O’Gorman P. Effect of propranolol and phentolamine on myocardial necrosis after subarachnoid haemorrhage. Br Med J. 1978;2:990–2.PubMedCrossRef
46.
Saito R, Takahashi T, Noshita N, et al. Takotsubo cardiomyopathy induced by dobutamine infusion during hypertensive therapy for symptomatic vasospasm after subarachnoid hemorrhage—case report. Neurol Med Chir (Tokyo). 2010;50:393–5.CrossRef
47.
Mutoh T, Ishikawa T, Suzuki A, Yasui N. Continuous cardiac output and near-infrared spectroscopy monitoring to assist in management of symptomatic cerebral vasospasm after subarachnoid hemorrhage. Neurocrit Care. 2010;13:331–8.PubMedCrossRef
48.
Busani S, Rinaldi L, Severino C, Cobelli M, Pasetto A, Girardis M. Levosimendan in cardiac failure after subarachnoid hemorrhage. J Trauma. 2010;68:E108–10.PubMedCrossRef
49.
Mutoh T, Kazumata K, Ishikawa T, Terasaka S. Performance of bedside transpulmonary thermodilution monitoring for goal-directed hemodynamic management after subarachnoid hemorrhage. Stroke. 2009;40:2368–74.PubMedCrossRef
50.
Taccone FS, Lubicz B, Piagnerelli M, Van Nuffelen M, Vincent JL, De Backer D. Cardiogenic shock with stunned myocardium during triple-H therapy treated with intra-aortic balloon pump counterpulsation. Neurocrit Care. 2009;10:76–82.PubMedCrossRef
51.
Kim DH, Haney CL, Van Ginhoven G. Reduction of pulmonary edema after SAH with a pulmonary artery catheter-guided hemodynamic management protocol. Neurocrit Care. 2005;3:11–5.PubMedCrossRef
52.
Deehan SC, Grant IS. Haemodynamic changes in neurogenic pulmonary oedema: effect of dobutamine. Intensive Care Med. 1996;22:672–6.PubMedCrossRef
53.
Apostolides PJ, Greene KA, Zabramski JM, Fitzgerald JW, Spetzler RF. Intra-aortic balloon pump counterpulsation in the management of concomitant cerebral vasospasm and cardiac failure after subarachnoid hemorrhage: technical case report. Neurosurgery. 1996;38:1056–9.PubMedCrossRef
54.
Miller JA, Dacey RG Jr, Diringer MN. Safety of hypertensive hypervolemic therapy with phenylephrine in the treatment of delayed ischemic deficits after subarachnoid hemorrhage. Stroke. 1995;26:2260–6.PubMedCrossRef
55.
Levy ML, Rabb CH, Zelman V, Giannotta SL. Cardiac performance enhancement from dobutamine in patients refractory to hypervolemic therapy for cerebral vasospasm. J Neurosurg. 1993;79:494–9.PubMedCrossRef
56.
Sheikhazadi A, Gharehdaghi J. Survey of sudden death from aneurysmal subarachnoid hemorrhage in cadavers referred to Legal Medicine Organization of Tehran, 2001–2005. Am J Forensic Med Pathol. 2009;30:358–61.PubMedCrossRef
57.
Naidech AM, Bassin SL, Garg RK, et al. Cardiac troponin I and acute lung injury after subarachnoid hemorrhage. Neurocrit Care. 2009;11:177–82.PubMedCrossRef
58.
Kramer AH, Bleck TP, Dumont AS, Kassell NF, Olson C, Nathan B. Implications of early versus late bilateral pulmonary infiltrates in patients with aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2009;10:20–7.PubMedCrossRef
59.
Muroi C, Keller M, Pangalu A, Fortunati M, Yonekawa Y, Keller E. Neurogenic pulmonary edema in patients with subarachnoid hemorrhage. J Neurosurg Anesthesiol. 2008;20:188–92.PubMedCrossRef
60.
Wartenberg KE, Schmidt JM, Claassen J, et al. Impact of medical complications on outcome after subarachnoid hemorrhage. Crit Care Med. 2006;34:617–23.PubMedCrossRef
61.
Kahn JM, Caldwell EC, Deem S, Newell DW, Heckbert SR, Rubenfeld GD. Acute lung injury in patients with subarachnoid hemorrhage: incidence, risk factors, and outcome. Crit Care Med. 2006;34:196–202.PubMedCrossRef
62.
Vespa PM, Bleck TP. Neurogenic pulmonary edema and other mechanisms of impaired oxygenation after aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2004;1:157–70.PubMedCrossRef
63.
Friedman JA, Pichelmann MA, Piepgras DG, et al. Pulmonary complications of aneurysmal subarachnoid hemorrhage. Neurosurgery. 2003;52:1025–31.PubMedCrossRef
64.
Smith WS, Matthay MA. Evidence for a hydrostatic mechanism in human neurogenic pulmonary edema. Chest. 1997;111:1326–33.PubMedCrossRef
65.
Solenski NJ, Haley EC Jr, Kassell NF, et al. Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study. Participants of the multicenter cooperative aneurysm study. Crit Care Med. 1995;23:1007–17.PubMedCrossRef
66.
van der Bilt IA, Hasan D, Vandertop WP, et al. Impact of cardiac complications on outcome after aneurysmal subarachnoid hemorrhage: a meta-analysis. Neurology. 2009;72:635–42.PubMedCrossRef
67.
Coghlan LA, Hindman BJ, Bayman EO, et al. Independent associations between electrocardiographic abnormalities and outcomes in patients with aneurysmal subarachnoid hemorrhage: findings from the intraoperative hypothermia aneurysm surgery trial. Stroke. 2009;40:412–8.PubMedCrossRef
68.
Hadeishi H, Mizuno M, Suzuki A, Yasui N. Hyperdynamic therapy for cerebral vasospasm. Neurol Med Chir (Tokyo). 1990;30:317–23.CrossRef
69.
Joseph M, Ziadi S, Nates J, Dannenbaum M, Malkoff M. Increases in cardiac output can reverse flow deficits from vasospasm independent of blood pressure: a study using xenon computed tomographic measurement of cerebral blood flow. Neurosurgery. 2003;53:1044–51.PubMedCrossRef
70.
Medlock MD, Dulebohn SC, Elwood PW. Prophylactic hypervolemia without calcium channel blockers in early aneurysm surgery. Neurosurgery. 1992;30:12–6.PubMedCrossRef
71.
Raabe A, Beck J, Keller M, Vatter H, Zimmermann M, Seifert V. Relative importance of hypertension compared with hypervolemia for increasing cerebral oxygenation in patients with cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg. 2005;103:974–81.PubMedCrossRef
72.
Treggiari-Venzi MM, Suter PM, Romand JA. Review of medical prevention of vasospasm after aneurysmal subarachnoid hemorrhage: a problem of neurointensive care. Neurosurgery. 2001;48:249–61.PubMed
Metadata
Title
Cardiovascular and Pulmonary Complications of Aneurysmal Subarachnoid Hemorrhage
Publication date
01-10-2011
Published in
Neurocritical Care / Issue 2/2011
Print ISSN: 1541-6933
Electronic ISSN: 1556-0961
DOI
https://doi.org/10.1007/s12028-011-9598-4

Other articles of this Issue 2/2011

Neurocritical Care 2/2011 Go to the issue

OriginalPaper

Triggers for Aggressive Interventions in Subarachnoid Hemorrhage

Review

Monitoring and Detection of Vasospasm II: EEG and Invasive Monitoring

Review

Hemodynamic Management of Subarachnoid Hemorrhage

Review

Vasospasm Versus Delayed Cerebral Ischemia as an Outcome Event in Clinical Trials and Observational Studies

Review

Summary of Evidence on Immediate Statins Therapy Following Aneurysmal Subarachnoid Hemorrhage

Review

Fever Management in SAH